Upgrade to SI Premium - Free Trial

Ziopharm Oncology (ZIOP) Reports First Patient Enrollment in Phase 1 Trial Evaluating Combination Therapy of Controlled IL-12 and OPDIVO

June 28, 2018 4:02 PM
Ziopharm Oncology, Inc. (NASDAQ: ZIOP) today announced that it has enrolled the first patient in its Phase 1 clinical trial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Management Comments

Next Articles